FÜLÖPOVÁ, Nicole, Natalia CHOMOVA, Jan ELBL, Dagmar MUDRONOVA, Patrik SIVULIČ, Sylvie PAVLOKOVÁ a Aleš FRANC. Preparation and Evaluation of a Dosage Form for Individualized Administration of Lyophilized Probiotics. Pharmaceutics. Basel: MDPI, 2023, roč. 15, č. 3, s. 1-19. ISSN 1999-4923. Dostupné z: https://dx.doi.org/10.3390/pharmaceutics15030910.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Preparation and Evaluation of a Dosage Form for Individualized Administration of Lyophilized Probiotics
Autoři FÜLÖPOVÁ, Nicole (703 Slovensko, domácí), Natalia CHOMOVA, Jan ELBL (203 Česká republika, domácí), Dagmar MUDRONOVA, Patrik SIVULIČ (703 Slovensko, domácí), Sylvie PAVLOKOVÁ (203 Česká republika, garant, domácí) a Aleš FRANC (203 Česká republika, domácí).
Vydání Pharmaceutics, Basel, MDPI, 2023, 1999-4923.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.400 v roce 2022
Kód RIV RIV/00216224:14160/23:00130704
Organizační jednotka Farmaceutická fakulta
Doi http://dx.doi.org/10.3390/pharmaceutics15030910
UT WoS 000960126700001
Klíčová slova anglicky lyophilization; antropozoonoses; probiotic bacteria; individual treatment; principal component analysis; viability of bacteria
Štítky rivok, ÚFT
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Daniela Černá, učo 489184. Změněno: 5. 4. 2024 07:41.
Anotace
Probiotics have been used in human and veterinary medicine to increase resistance to pathogens and provide protection against external impacts for many years. Pathogens are often transmitted to humans through animal product consumption. Therefore, it is assumed that probiotics protecting animals may also protect the humans who consume them. Many tested strains of probiotic bacteria can be used for individualized therapy. The recently isolated Lactobacillus plantarum R2 Biocenol™ has proven to be preferential in aquaculture, and potential benefits in humans are expected. A simple oral dosage form should be developed to test this hypothesis by a suitable preparation method, i.e., lyophilization, allowing the bacteria to survive longer. Lyophilizates were formed from silicates (Neusilin® NS2N; US2), cellulose derivates (Avicel® PH-101), and saccharides (inulin; saccharose; modified starch® 1500). They were evaluated for their physicochemical properties (pH leachate, moisture content, water absorption, wetting time, DSC tests, densities, and flow properties); their bacterial viability was determined in conditions including relevant studies over 6 months at 4 °C and scanned under an electron microscope. Lyophilizate composed of Neusilin® NS2N and saccharose appeared to be the most advantageous in terms of viability without any significant decrease. Its physicochemical properties are also suitable for capsule encapsulation, subsequent clinical evaluation, and individualized therapy.
Návaznosti
EF19_073/0016943, projekt VaVNázev: Interní grantová agentura Masarykovy univerzity
MUNI/IGA/0942/2021, interní kód MUNázev: Formulation of dosage form with probiotics (Lactobacillus) for an oral administration (Akronym: FODPOA)
Investor: Masarykova univerzita, Formulation of dosage form with probiotics (Lactobacillus) for an oral administration
VytisknoutZobrazeno: 19. 7. 2024 09:41